Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients

SIMPLE SUMMARY: Hypolipidemic drugs are among the most frequently prescribed medications in the Western world. Since many studies have indicated their role in carcinogenesis, this work aimed to investigate their association with the occurrence of a second primary malignancy in colorectal cancer surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Halámková, Jana, Bohovicová, Lucia, Pehalová, Lucie, Goněc, Roman, Staněk, Teodor, Kazda, Tomáš, Mouková, Lucie, Krákorová, Dagmar Adámková, Kozáková, Šárka, Svoboda, Marek, Demlová, Regina, Kiss, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997159/
https://www.ncbi.nlm.nih.gov/pubmed/35406471
http://dx.doi.org/10.3390/cancers14071699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997159/
https://www.ncbi.nlm.nih.gov/pubmed/35406471
http://dx.doi.org/10.3390/cancers14071699

Ejemplares similares